Phencyclidine cardiovascular

The Committee found the evidence on the long-term health effects of the tested psychochemicals to be sparse. The target organs that may be involved in prolonged or delayed effects of phencyclidine are the brain and cardiovascular system. Target mental or cardiovascular effects did not take place within a week of exposure to the drug. No case reports have identified long-term effects or mental or cardiovascular effects soon after first exposure. 

Phencyclidine (PCP) was developed in late 1950 as an intravenous anesthetic agent. PCP produces anesthesia and analgesia with respiratory or cardiovascular depression. However, postoperatively, the drug produced psychotomimetic effects (e.g., delirium and hallucinations) and was subsequently withdrawn from the market. 

Ketamine is a potent analgesic-anesthetic that is also effective intramuscularly. One particular property, production of cardiovascular stimulation, is of special advantage in elderly patients and those in shock (e.g., from bums). However, its propensity to precipitate hallucinations, delirium, disorientation, and other perceptual illusions postoperatively in about 12% of patients has led to its infrequent use in the United States. Ketamine s close structural analogy to the notorious and dangerous hallucinogen, phencyclidine (PCP, angel dust ), should be noted. This drug, which was first also introduced as an... 

CNS Central nervous system CVS Cardiovascular system CIT Gastrointestinal tract LSD Lysergic acid diethylamide PCP Phencyclidine... 

---